Skip to main content
. 2020 Jan 31;105(4):1145–1156. doi: 10.1210/clinem/dgaa047

Table 2.

Multivariable regression models for the determinants of 24-hour urinary norepinephrine and epinephrine excretion rates during isocaloric conditions

Urinary Norepinephrine (μg/24h) Log10-transformed Urinary Epinephrine (μg/24h) Log10-transformed
Explained variance (global P value) R 2 =0.20 P < .001 R 2 =0.16 P = .004
Age, y 0.002 ± 0.002 –0.001 ± 0.002
(–0.001, 0.005) (–0.004, 0.002)
Partial r: 0.105 Partial r: –0.032
P = .16 P = .67
Sex (male) 0.06 ± 0.05 0.1 ± 0.05
(–0.03, 0.15) (0.01, 0.19)
Partial r: 0.09 Partial r: 0.16
P = .21 P = .03
Ethnicity (White) –0.1 ± 0.12 –0.11 ± 0.12
(–0.34, 0.13) (–0.35, 0.12)
Partial r: –0.07 Partial r: –0.07
P = 0.38 P = 0.33
Ethnicity (Native American) –0.05 ± 0.12 –0.15 ± 0.12
(–0.28, 0.18) (–0.39, 0.08)
Partial r: –0.03 Partial r: –0.1
P = .65 P = .20
Ethnicity (black) –0.08 ± 0.12 –0.03 ± 0.12
(–0.32, 0.16) (–0.27, 0.21)
Partial r: –0.05 Partial r: –0.02
P = .50 P = .81
Ethnicity (Hispanic) –0.05 ± 0.12 –0.03 ± 0.12
(–0.29, 0.19) (–0.27, 0.22)
Partial r: –0.03 Partial r: –0.02
P = .70 P = .83
Percentage body fat (%) 0.001 ± 0.003 –0.003 ± 0.003
(–0.005, 0.006) (–0.008, 0.003)
Partial r: 0.021 Partial r: –0.073
P = .78 P = .33
Fasting glucose 0.002 ± 0.002 –0.0014 ± 0.0022
(–0.003, 0.006) (–0.0058, 0.003)
Partial r: 0.052 Partial r: –0.0465
P = .49 P = .53
Fasting insulin(log10- transformed) 0.22 ± 0.06 0.03 ± 0.06
(0.11, 0.34) (–0.08, 0.14)
Partial r: 0.28 Partial r: 0.04
P = 0.001 P = .59
Storage time, mo 0.00003 ± 0.00002 0.000004 ± 0.000019
(–0.00001, 0.00006) (–0.000034, 0.000041)
Partial r: 0.11 Partial r: 0.01
P = .16 P = .85
Intercept 0.52 ± 0.46 0.73 ± 0.47
(–0.4, 1.44) (–0.19, 1.66)
P = .26 P = .12

The β coefficient estimate in each cell is reported with ± SE and the 95% CI in parentheses, along with partial correlations and P value. Significant results are highlighted in bold.

Similar results were obtained when introducing the 3-hour total area under the curve (AUC) of the insulin/glucose response during the oral glucose tolerance test (model with norepinephrine: AUC insulin: partial r = 0.21, P = .005) into the linear model in place of fasting insulin/glucose, when introducing body mass index in the linear model in place of percentage body fat, and after excluding individuals with impaired glucose tolerance (n = 65).